Table 3.
Marginal effects of NI-T2D and coexisting diseases on the HRQoL of respondents as measured with the EQ-5D-5 L and EQ-5D-3 L crosswalk values
| Non-diabetics without coexisting diseases as reference group | Difference in quality of life compared to non-diabetic persons with no coexisting diseases | |
| Category, number of coexisting diseases | EQ-5D-5 L index score (95% CI) | EQ-5D-3 L crosswalk index score (95% CI) |
| No T2D, 0 | 0 (reference) | 0 (reference) |
| No T2D, 1 | −0.053 (−0.061 to −0.046) | −0.079 (−0.089 to −0.069) |
| No T2D, 2 | −0.091 (− 0.103 to − 0.079) | − 0.121 (− 0.135 to − 0.107) |
| No T2D, 3 | − 0.100 (− 0.116 to − 0.083) | −0.136 (− 0.155 to − 0.118) |
| No T2D, 4 ≥ | −0.196 (− 0.235 to − 0.157) | −0.227 (− 0.261 to − 0.193) |
| NI-T2D, 0 | −0.015 (− 0.051 to 0.020) | −0.021 (− 0.073 to 0.031) |
| NI-T2D, 1 | − 0.060 (− 0.084 to − 0.036) | −0.083 (− 0.113 to − 0.053) |
| NI-T2D, 2 | −0.063 (− 0.084 to − 0.041) | −0.086 (− 0.112 to − 0.060) |
| NI-T2D, 3 | −0.097 (− 0.122 to − 0.073) | −0.133 (− 0.160 to − 0.106) |
| NI-T2D, 4 ≥ | −0.222 (− 0.279 to − 0.164) | −0.247 (− 0.296 to − 0.199) |
| All non-diabetics together as reference group | Difference in quality of life compared to non-diabetic persons | |
| Number of coexisting diseases | EQ-5D-5 L index score (95% CI) | EQ-5D-3 L crosswalk index score (95% CI) |
| No T2D | 0 (reference) | 0 (reference) |
| NI-T2D, 0 | 0.028 (−0.006 to 0.062) | 0.039 (−0.012 to 0.090) |
| NI-T2D, 1 | −0.014 (− 0.038 to 0.009) | −0.020 (− 0.049 to 0.010) |
| NI-T2D, 2 | − 0.013 (− 0.033 to 0.007) | −0.019 (− 0.044 to 0.007) |
| NI-T2D, 3 | − 0.043 (− 0.066 to − 0.019) | −0.064 (− 0.091 to − 0.036) |
| NI-T2D, ≥4 | −0.152 (− 0.207 to − 0.097) | −0.170 (− 0.219 to − 0.121) |
Results were adjusted for age, sex, income, education, marital status, survey type and employment